01/23/2025
4:41 PM | Intellia Therapeutics (Issuer)
Schultes Birgit C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/10/2025
6:30 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
10:29 AM | Intellia Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/07/2025
4:20 PM | Hicks Derek (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:20 PM | Intellia Therapeutics (Issuer)
Lebwohl David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:22 PM | BASTA JAMES (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:23 PM | Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
6:00 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
3:59 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:29 PM | Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/08/2024
6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
3:17 PM | Dulac Edward J III (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:13 PM | Dulac Edward J III (Reporting)
Intellia Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
3:03 PM | Intellia Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/03/2024
12:15 PM | Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
12:15 PM | Clark Eliana (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
7:06 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
4:00 PM | Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:14 PM | Goff Brian (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:15 PM | Goff Brian (Reporting)
Intellia Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/14/2024
3:16 PM | CHASE WILLIAM J (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:18 PM | Bhanji Muna (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:19 PM | Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:21 PM | Intellia Therapeutics (Issuer)
Keresty Georgia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:22 PM | Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:25 PM | Intellia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:40 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:16 PM | Intellia Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:10 PM | Dube Michael P (Reporting)
Intellia Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/15/2024
3:21 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
8:26 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
6:04 AM | Intellia Therapeutics (Filer)
| Form 424B5 | |
02/23/2024
4:22 PM | Intellia Therapeutics (Filer)
| Form 424B5 | |
02/23/2024
4:17 PM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:45 AM | Intellia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free NTLA Stock Alerts